Annals of Hematology

, Volume 87, Issue 6, pp 495–496 | Cite as

Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine

Letter to the Editor

References

  1. 1.
    Zupancic M, Shah PC, Shah-Khan F (2007) Gemcitabine-associated thrombotic thrombocytopenic purpura. Lancet Oncol 8:634–641PubMedCrossRefGoogle Scholar
  2. 2.
    Lewin SN, Mutch DG, Withcomb BP et al (2005) Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol 97:228–233PubMedCrossRefGoogle Scholar
  3. 3.
    Citarrella P, Gebbia V, Teresi M et al (2002) Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report. Anticancer Res 22:1183–1185PubMedGoogle Scholar
  4. 4.
    Alberts SR, Townley PM, Goldberg RM et al (2003) Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. Ann Oncol 14:580–585PubMedCrossRefGoogle Scholar
  5. 5.
    Muller S, Schutt P, Bojko P et al (2005) Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol 84:110–114PubMedCrossRefGoogle Scholar
  6. 6.
    Furlan M, Robles R, Galbusera M et al (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 339:1578–1584PubMedCrossRefGoogle Scholar
  7. 7.
    George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354:1927–1935PubMedCrossRefGoogle Scholar
  8. 8.
    Vessely SK, George JN, Lammle B et al (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102:60–68CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Department of HematologyUniversitair Ziekenhuis BrusselBrusselsBelgium
  2. 2.Department of Medical OncologyUniversitair Ziekenhuis BrusselBrusselsBelgium

Personalised recommendations